CONMED Corporation Announces Fourth Quarter and Full-Year 2021 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/18/2026
- Wall St slips as higher Treasury yields weigh on sentiment
- Oil pares losses as market weighs Saudi supply concerns, Middle East tensions
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
Conmed (CNMD) Tops Q4 EPS by 1c
January 26, 2022 4:24 PM ESTConmed (NYSE: CNMD) reported Q4 EPS of $1.07, $0.01 better than the analyst estimate of $1.06. Revenue for the quarter came in at $274 million versus the consensus estimate of $278.76 million.
GUIDANCE:
Conmed sees FY2022 EPS of $3.60-$3.85, versus the consensus of $3.74. Conmed sees... More
